Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-17

Clinical Trial Update: Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating febuxostat's effects on blood pressure and the intrarenal renin-angiotensin system; results were posted after completion in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Uloric (febuxostat)

Snippet

Sponsor: Paul N. Hopkins | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2015-09-17